Work

NOTCH3 p.R544C Drives Early Neurovascular Unit Dysfunction through Blood-Brain Barrier Failure, Complement Signalling and Metabolic Dysregulation

Year: 2026
Type: preprint
Abstract: Cerebral small vessel disease is a major cause of stroke and vascular cognitive impairment, yet the mechanisms that initiate neurovascular dysfunction before irreversible brain injury remain poorly defined. CADASIL, caused by cysteine-altering NOTCH3 mutations, provides a genetically tractable model to resolve these early events. Here, we investigated the Asian-enriched NOTCH3 p.R544C variant and tested whether early disease emerges through interconnected blood-brain barrier (BBB), inflammatory, and metabolic dysfunction. NOTCH3 p.R544C iPSC-derived endothelial cells showed impaired angiogenesis and migration, reduced barrier resistance, disrupted tight-junction organisation, and altered vascular, adhesion, and extracellular-matrix programmes. In multicellular BBB-like microtissues, these defects propagated across the neurovascular unit, producing disorganised vascular networks, enlarged luminal structures, and increased permeability, establishing BBB failure as an early disease layer. Single-cell transcriptomics revealed coordinated loss of endothelial BBB transport and efflux programmes with astrocytic complement, innate immune, and matrix-remodelling activation. Secretome profiling and patient-plasma measurements converged on complement- and matrix-associated mediators, including C1S and CLU, identifying complement-matrix activation as a second interconnected layer. Importantly, combined cilostazol and isosorbide mononitrate treatment improved barrier function and reduced selected complement- and matrix-associated proteins in mutant microtissues, supporting pharmacological reversibility of components of this early disease programme. Seahorse analysis further demonstrated reduced mitochondrial respiratory capacity associated with NOTCH3 p.R544C. In vivo, three-month-old mutant mice showed altered cerebral pyruvate metabolism and early microvascular abnormalities, whereas six-month-old mice developed more prominent extracellular-matrix, inflammatory, and gliovascular changes, supporting an age-dependent transition from early metabolic dysregulation to broader neurovascular remodelling. Together, these findings define NOTCH3 p.R544C CADASIL as an early multicellular neurovascular disorder organised across three interconnected mechanistic layers: BBB failure, complement-matrix signalling, and metabolic dysregulation, while identifying early BBB-centred dysfunction as a potentially tractable state before advanced cerebrovascular injury develops.
Language: English
Subfield: Neurology
Open Access status: green
OpenAlex ID: W7237340213
Cites:
Cited by:
Related to: